Tag Archives: coronary heart disease
March 2008 Br J Cardiol 2008;15:83-85
Low-density lipoprotein-apheresis: an update
Stefanos Archontakis, Alison Pottle, Mahmoud Barbir
Indications, techniques and effects Low density lipoprotein (LDL)-apheresis is a selective lipid-lowering extracorporeal treatment where LDL and other atherogenic apoB-lipoproteins are removed from circulation while high-density lipoprotein (HDL) remains virtually unchanged. In the last years, individual authors as well as various scientific organisations have proposed different indications for using LDL-apheresis. The most widely used guidelines are those of the Food and Drug Administration (FDA) in the USA,1 of the Federal Committee of Physicians and Health Insurance Funds in Germany2 and recently, those of the International Panel on the M
March 2008 Br J Cardiol 2008;15:95-100
A UK survey of rosuvastatin in general practice: reaching cholesterol targets
George Kassianos, John Reckless, Cathy Emmas, Marc Evans, Andrea Tree, Andrew Vance
Introduction Coronary heart disease (CHD) is responsible for over 100,000 deaths annually in the UK.1 Epidemiology studies have long supported that cholesterol is a key risk factor for cardiovascular disease (CVD).2 In both primary and secondary prevention, statin therapy trials have shown that there is a clear relationship between lowering cholesterol and reducing cardiovascular risk in both primary and secondary prevention.3 However, The World Health Report 2002 estimates that over 50% of CHD globally is still due to elevated blood cholesterol levels.4 Table 1. Recommended targets for total cholesterol (TC) and low-density lipoprotein chol
September 2007 Br J Cardiol 2007;14:203-04
Women and heart disease
Dr Alan Begg
No content available
May 2007 Br J Cardiol 2007;14:129-30
Protecting the heart by postconditioning
Derek J Hausenloy, Derek M Yellon
No content available
March 2007 Br J Cardiol 2007;14:117-119
Audit of the new GMS contract Quality and Outcomes Framework: raising standards in CHD
Janet McCarlie, Elisabet Reid, Adrian JB Brady
No content available
January 2007 Br J Cardiol 2007;14:51-55
A pilot study on computer-based opportunistic screening for coronary heart disease: universal assessment and education in primary care
Peter F Tyerman, Gill V Tyerman, Ruth Bacigalupo
No content available
November 2006 Br J Cardiol 2006;13:367-9
The impact of the new GP contract on measurement of lipids and use of statins in the over 80s with coronary heart disease
Samira Siddiqui, Chris Isles, Ewan Bell, Alan Begg
No content available
March 2006 Br J Cardiol 2006;13:145-52
The ‘rule of halves’ still applies to the management of cholesterol in cardiovascular disease: 2002–2005
Simon de Lusignan, Nigel Hague, Jonathan Belsey, Neil Dhoul, Jeremy van Vlymen
No content available
January 2006 Br J Cardiol 2006;13:36-41
Meeting the NSF targets for door-to-needle time in acute myocardial infarction – the role of a bolus thrombolytic
Velmurugan C Kuppuswamy, Daniela Webbe, Sandeep Gupta
No content available
September 2005 Br J Cardiol 2005;12:401-3
Peripheral arterial disease – CVD by any other name?
Sarah Jarvis
No content available
For healthcare professionals only
